The development and validation of a nocturnal gastro-oesophageal reflux disease symptom severity and impact questionnaire for adults

B. M. Spiegel, Lewis Rowland Roberts, R. Mody, G. Harding, S. Kothari-Talwar, P. J. Kahrilas, Michael Camilleri, O. Dabbous, D. A. Revicki

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background Current questionnaires for assessing gastro-oesophageal reflux disease (GERD) symptoms are limited in their ability to capture nocturnal symptoms. Aim To develop and validate an instrument, the Nocturnal Gastro-oesophageal Reflux Disease Symptom Severity and Impact Questionnaire (N-GSSIQ), to assess severity and impact of nocturnal GERD symptoms. Methods Two focus groups and 16 cognitive debriefing interviews were conducted among GERD patients to identify key issues about nocturnal symptoms. A draft instrument was tested in 196 patients at 11 clinics in the US to evaluate psychometric properties. Exploratory factor and item response theory analyses were conducted to finalize items and subscales. Internal consistency reliability, reproducibility and construct validity were examined. Results Mean age was 45 (s.d. = 13.8) years; 76% were female and 68% were Caucasian. Patient-rated severity was mild-moderate for 69% of participants; 48% reported symptoms on two to three nights the past week. The final questionnaire includes 20 items and three subscales: Nocturnal GERD Symptoms, Morning Impact of Nocturnal GERD and Concern about Nocturnal GERD. The subscales demonstrated internal consistency reliability (Cronbach's alpha 0.84-0.94) and were significantly correlated with similar measures and disease severity (0.41-0.81; P < 0.0001). Conclusion The results support the reliability and validity of the N-GSSIQ as a measure of severity, morning impact and concern about nocturnal GERD.

Original languageEnglish (US)
Pages (from-to)591-602
Number of pages12
JournalAlimentary Pharmacology and Therapeutics
Volume32
Issue number4
DOIs
StatePublished - Aug 2010

Fingerprint

Esophageal Diseases
Gastroesophageal Reflux
Surveys and Questionnaires
Aptitude
Focus Groups
Psychometrics
Reproducibility of Results
Interviews

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

The development and validation of a nocturnal gastro-oesophageal reflux disease symptom severity and impact questionnaire for adults. / Spiegel, B. M.; Roberts, Lewis Rowland; Mody, R.; Harding, G.; Kothari-Talwar, S.; Kahrilas, P. J.; Camilleri, Michael; Dabbous, O.; Revicki, D. A.

In: Alimentary Pharmacology and Therapeutics, Vol. 32, No. 4, 08.2010, p. 591-602.

Research output: Contribution to journalArticle

Spiegel, B. M. ; Roberts, Lewis Rowland ; Mody, R. ; Harding, G. ; Kothari-Talwar, S. ; Kahrilas, P. J. ; Camilleri, Michael ; Dabbous, O. ; Revicki, D. A. / The development and validation of a nocturnal gastro-oesophageal reflux disease symptom severity and impact questionnaire for adults. In: Alimentary Pharmacology and Therapeutics. 2010 ; Vol. 32, No. 4. pp. 591-602.
@article{1b83ad80f20d433baa1b8c5f4ed33008,
title = "The development and validation of a nocturnal gastro-oesophageal reflux disease symptom severity and impact questionnaire for adults",
abstract = "Background Current questionnaires for assessing gastro-oesophageal reflux disease (GERD) symptoms are limited in their ability to capture nocturnal symptoms. Aim To develop and validate an instrument, the Nocturnal Gastro-oesophageal Reflux Disease Symptom Severity and Impact Questionnaire (N-GSSIQ), to assess severity and impact of nocturnal GERD symptoms. Methods Two focus groups and 16 cognitive debriefing interviews were conducted among GERD patients to identify key issues about nocturnal symptoms. A draft instrument was tested in 196 patients at 11 clinics in the US to evaluate psychometric properties. Exploratory factor and item response theory analyses were conducted to finalize items and subscales. Internal consistency reliability, reproducibility and construct validity were examined. Results Mean age was 45 (s.d. = 13.8) years; 76{\%} were female and 68{\%} were Caucasian. Patient-rated severity was mild-moderate for 69{\%} of participants; 48{\%} reported symptoms on two to three nights the past week. The final questionnaire includes 20 items and three subscales: Nocturnal GERD Symptoms, Morning Impact of Nocturnal GERD and Concern about Nocturnal GERD. The subscales demonstrated internal consistency reliability (Cronbach's alpha 0.84-0.94) and were significantly correlated with similar measures and disease severity (0.41-0.81; P < 0.0001). Conclusion The results support the reliability and validity of the N-GSSIQ as a measure of severity, morning impact and concern about nocturnal GERD.",
author = "Spiegel, {B. M.} and Roberts, {Lewis Rowland} and R. Mody and G. Harding and S. Kothari-Talwar and Kahrilas, {P. J.} and Michael Camilleri and O. Dabbous and Revicki, {D. A.}",
year = "2010",
month = "8",
doi = "10.1111/j.1365-2036.2010.04385.x",
language = "English (US)",
volume = "32",
pages = "591--602",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - The development and validation of a nocturnal gastro-oesophageal reflux disease symptom severity and impact questionnaire for adults

AU - Spiegel, B. M.

AU - Roberts, Lewis Rowland

AU - Mody, R.

AU - Harding, G.

AU - Kothari-Talwar, S.

AU - Kahrilas, P. J.

AU - Camilleri, Michael

AU - Dabbous, O.

AU - Revicki, D. A.

PY - 2010/8

Y1 - 2010/8

N2 - Background Current questionnaires for assessing gastro-oesophageal reflux disease (GERD) symptoms are limited in their ability to capture nocturnal symptoms. Aim To develop and validate an instrument, the Nocturnal Gastro-oesophageal Reflux Disease Symptom Severity and Impact Questionnaire (N-GSSIQ), to assess severity and impact of nocturnal GERD symptoms. Methods Two focus groups and 16 cognitive debriefing interviews were conducted among GERD patients to identify key issues about nocturnal symptoms. A draft instrument was tested in 196 patients at 11 clinics in the US to evaluate psychometric properties. Exploratory factor and item response theory analyses were conducted to finalize items and subscales. Internal consistency reliability, reproducibility and construct validity were examined. Results Mean age was 45 (s.d. = 13.8) years; 76% were female and 68% were Caucasian. Patient-rated severity was mild-moderate for 69% of participants; 48% reported symptoms on two to three nights the past week. The final questionnaire includes 20 items and three subscales: Nocturnal GERD Symptoms, Morning Impact of Nocturnal GERD and Concern about Nocturnal GERD. The subscales demonstrated internal consistency reliability (Cronbach's alpha 0.84-0.94) and were significantly correlated with similar measures and disease severity (0.41-0.81; P < 0.0001). Conclusion The results support the reliability and validity of the N-GSSIQ as a measure of severity, morning impact and concern about nocturnal GERD.

AB - Background Current questionnaires for assessing gastro-oesophageal reflux disease (GERD) symptoms are limited in their ability to capture nocturnal symptoms. Aim To develop and validate an instrument, the Nocturnal Gastro-oesophageal Reflux Disease Symptom Severity and Impact Questionnaire (N-GSSIQ), to assess severity and impact of nocturnal GERD symptoms. Methods Two focus groups and 16 cognitive debriefing interviews were conducted among GERD patients to identify key issues about nocturnal symptoms. A draft instrument was tested in 196 patients at 11 clinics in the US to evaluate psychometric properties. Exploratory factor and item response theory analyses were conducted to finalize items and subscales. Internal consistency reliability, reproducibility and construct validity were examined. Results Mean age was 45 (s.d. = 13.8) years; 76% were female and 68% were Caucasian. Patient-rated severity was mild-moderate for 69% of participants; 48% reported symptoms on two to three nights the past week. The final questionnaire includes 20 items and three subscales: Nocturnal GERD Symptoms, Morning Impact of Nocturnal GERD and Concern about Nocturnal GERD. The subscales demonstrated internal consistency reliability (Cronbach's alpha 0.84-0.94) and were significantly correlated with similar measures and disease severity (0.41-0.81; P < 0.0001). Conclusion The results support the reliability and validity of the N-GSSIQ as a measure of severity, morning impact and concern about nocturnal GERD.

UR - http://www.scopus.com/inward/record.url?scp=77954717037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954717037&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2036.2010.04385.x

DO - 10.1111/j.1365-2036.2010.04385.x

M3 - Article

C2 - 20528826

AN - SCOPUS:77954717037

VL - 32

SP - 591

EP - 602

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 4

ER -